🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well a survivin peptide vaccine called SurVax...
Status
Not Yet Recruiting
Location
Rocky Mountain Regional VA Medical Center
Start Date
2026-10-01
Trial ID
NCT07169617
The main purpose of this study is to determine whether adding SurVaxM to st...
Status
Unknown
Location
University of California
Start Date
2021-11-18
Trial ID
NCT05163080
Treatments Being Tested
This phase IIa trial compares the safety and effect of temozolomide combine...
Status
Suspended
Location
Roswell Park Cancer Institute
Start Date
2026-10-15
Trial ID
NCT06202066
Data from clinical trials suggest that SurVaxM administered as a single age...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04802447
Treatments Being Tested
This phase II trial studies the side effects and how well vaccine therapy w...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Cancer Center
Start Date
2015-05-04
Trial ID
NCT02455557
Patients will receive a vaccine called SurVaxM on this study. While vaccine...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Start Date
2022-07-01
Trial ID
NCT04978727
The main purpose of this study is to assess the clinical activity of Pembro...
Status
Completed
Location
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
Start Date
2020-03-19
Trial ID
NCT04013672
Treatments Being Tested
This phase I trial studies the side effects of survivin long peptide vaccin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2019-06-17
Trial ID
NCT03879694
Treatments Being Tested